Patents by Inventor Ehud Ben-Hur
Ehud Ben-Hur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9474844Abstract: Methods for pathogen reduction in donor blood are performed by exposure of blood to UVC irradiation. Unwanted wavelengths of light, mostly in the infrared spectra, may be precluded from reaching blood by providing a layer of IR-absorbing fluid positioned between blood and the source of UV irradiation, whereby minimizing energy absorption and heating of blood. Some embodiments further disclose utilizing the same IR-absorbing fluid to actively cool blood by flowing the IR-absorbing fluid along the blood flow path.Type: GrantFiled: December 29, 2015Date of Patent: October 25, 2016Assignee: Hemalux LLCInventor: Ehud Ben-Hur
-
Patent number: 9265876Abstract: The systems and methods for pathogen reduction in donor blood operates by exposure of blood to UVC irradiation. Unwanted wavelengths of light, mostly in the infrared spectra, may be precluded from reaching blood by providing a layer of IR-absorbing fluid positioned between blood and the source of UV irradiation, whereby minimizing energy absorption and heating of blood. Some embodiments further disclose a system configured to utilize the same IR-absorbing fluid to actively cool blood by flowing along the flow path thereof.Type: GrantFiled: October 22, 2014Date of Patent: February 23, 2016Assignee: Hemalux Technologies LLCInventor: Ehud Ben-Hur
-
Patent number: 8883409Abstract: Disclosed are methods for pathogen reduction in blood by illuminating with UV light while taking steps for preservation of blood components and reducing oxidative damage from reactive oxygen species generated during UV light exposure. Fresh whole donor blood or products derived therefrom may be submitted to UV light treatment while in a low oxygenation state defined by a partial oxygen pressure below a normal level. Such low oxygenation state occurs naturally shortly after blood collection or may be induced by exposure to low-oxygen environment, reducing temperature or by other disclosed steps.Type: GrantFiled: December 8, 2013Date of Patent: November 11, 2014Assignee: Hemalux LLCInventor: Ehud Ben-Hur
-
Publication number: 20140097353Abstract: A system for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by a pump control system programmed to cause the pump to vary the flow of fluid. In embodiments, the pump may be automatically operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time.Type: ApplicationFiled: December 10, 2013Publication date: April 10, 2014Applicant: HEMALUX TECHNOLOGIES LLCInventors: Ehud Ben-Hur, Heather Balji
-
Publication number: 20140091045Abstract: A system and method for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by causing the pump to vary the flow of fluid. In embodiments, the pump may be operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time.Type: ApplicationFiled: December 5, 2013Publication date: April 3, 2014Applicant: HEMALUX TECHNOLOGIES LLCInventors: Ehud Ben-Hur, Heather Balji
-
Publication number: 20140086793Abstract: A system and method for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a pump configured to propagate the fluid through a serpentine-shaped flow path while exposing the fluid to UV irradiation. Extensive mixing of flow is accomplished by causing the pump to vary the flow of fluid. In embodiments, the pump may be operated to periodically switch the flow back and forth between a high flow rate and a slow flow rate. Alternatively, the pump may be periodically stopped or even cause the flow to reverse direction for short periods of time.Type: ApplicationFiled: August 17, 2013Publication date: March 27, 2014Applicant: HEMALUX TECHNOLOGIES LLCInventors: Ehud Ben-Hur, Heather Balji
-
Publication number: 20140084179Abstract: An exposure chamber for reducing pathogens in a biological fluid such as whole blood or blood-derived products includes a serpentine-shaped UV-transparent flow path and closely positioned ultraviolet light emitting diodes configured for emanating UV irradiation towards the biological fluid at peak wavelength of 250 nm to 270 nm. The control system is provided to energize UV LEDs using various novel modes of modulating pulse width and current amplitude for LEDs so as to deliver higher UV intensity to the biological fluid but without overheating thereof or the LEDs.Type: ApplicationFiled: August 26, 2013Publication date: March 27, 2014Applicant: Hemalux Technologies LLCInventors: Ehud Ben-Hur, Heather Balji
-
Patent number: 6541229Abstract: Disclosed is an improved process for irradiating cell-containing compositions, especially, red cell-containing compositions, wherein vitamin E or a derivative thereof is added to the cell-containing composition prior to, during or after such irradiation. Addition of vitamin E or a derivative thereof is protective of cells in such compositions, but not of virus. Cells irradiated using the inventive process show a reduced leakage of K+ from cells and also a reduced loss of negative charges from the cell membrane compared to cells subjected to the similar process wherein vitamin E or a derivative thereof are not used. In addition, red blood cells sterilized by this process are better preserved during storage and their life-time in the circulation in vivo is greatly enhanced.Type: GrantFiled: October 15, 1999Date of Patent: April 1, 2003Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Shanti Rywkin, Bernard Horowitz
-
Patent number: 6413714Abstract: The present invention concerns a process for inactivating extracellular and intracellular virus in a biological composition without incurring substantial disruption or inactivation thereof, said process comprising subjecting said composition to a virucidally effective amount of UVA1 irradiation substantially in the absence of UVA2 irradiation for a period of time sufficient to thereby inactivate said virus while retaining functionality of said composition. The biological composition is advantageously a product that contains red blood cells or platelets. The process is advantageously carried out in the presence of an irradiation sensitizer compound and/or a quencher. The present invention also concerns the product substantially identical to that produced by the inventive process.Type: GrantFiled: May 26, 2000Date of Patent: July 2, 2002Assignee: New York Blood Center, Inc.Inventors: Henrietta Margolis-Nunno, Ehud Ben-Hur, Bernard Horowitz
-
Patent number: 6365145Abstract: The present invention provides a method for removing hair from a selected skin area comprising the steps of (a) applying a liposome composition comprising a photosensitizer to the selected skin area so that the composition is introduced into hair follicle ducts of the skin area, wherein the photosensitizer is present in the composition in an amount effective to undergo a reaction and damage the hair follicles upon application to the skin area of light at an appropriate wavelength, energy and duration to penetrate the skin and activate the photosensitizer; (b) removing from the skin area substantially all of the liposome composition which is not introduced into the hair follicle ducts; and (c) applying light to the skin area at an appropriate wavelength, energy and duration to penetrate the skin and cause the photosensitizer to undergo a reaction to damage the hair follicles. The present invention also provides a composition useful for hair removal.Type: GrantFiled: June 5, 2000Date of Patent: April 2, 2002Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Maria M. Zuk, Wai-Shun Chan
-
Patent number: 6348453Abstract: The present invention provides a method for treating a viral infection in a subject in need of such treatment comprising administering to the subject a photosensitizer formulated in a liposome carrier, and exposing the subject to light at a wavelength 20-40 nm greater than the maximum absorption of the photosensitizer at a sufficient dose and duration to treat the viral infection in the subject. The present invention also provides a method for treating a viral infection in a subject in need of such treatment comprising administering to the subject (i) a photosensitizer formulated in a liposome carrier and (ii) at least one quencher, and exposing the subject to light at a sufficient wavelength, dose and duration to treat the viral infection in the subject.Type: GrantFiled: April 5, 2000Date of Patent: February 19, 2002Assignee: New York Blood Center, Inc.Inventor: Ehud Ben-Hur
-
Patent number: 6323012Abstract: The present invention provides a method for treating a viral infection in a subject. The method comprises administering to the subject an amount of 5-aminolevulinic acid to cause virus-infected cells to accumulate protoporphyrin in amounts such that upon application of a sufficient dose of red light, the virus-infected, protoporphyrin-accumulated cells will be destroyed; and applying a sufficient dose of red light to the virus-infected, protoporphyrin-accumulated cells to destroy the virus-infected, protoporphyrin-accumulated cells.Type: GrantFiled: January 21, 1999Date of Patent: November 27, 2001Assignees: New York Blood Center, Inc., Bar-Ilan UniversityInventors: Ehud Ben-Hur, Zvi Malik
-
Patent number: 6159733Abstract: The present invention provides a method for photoinactivating malignant cells in a cell sample. The method comprises incubating the cell sample with a concentration of Pc 4 effective to cause a substantial number of the malignant cells contained in the cell sample to absorb Pc 4 such that upon application of a sufficient dose of red light, the Pc 4 absorbed malignant cells will be photoinactivated; and applying a sufficient dose of red light to the cell sample to photoinactivate the Pc 4 absorbed malignant cells contained in the cell sample.Type: GrantFiled: June 20, 1996Date of Patent: December 12, 2000Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Robert A. Preti, Jan F. Keij
-
Patent number: 6143287Abstract: The present invention provides a method for removing hair from a selected skin area comprising the steps of (a) applying a liposome composition comprising a photosensitizer to the selected skin area so that the composition is introduced into hair follicle ducts of the skin area, wherein the photosensitizer is present in the composition in an amount effective to undergo a reaction and damage the hair follicles upon application to the skin area of light at an appropriate wavelength, energy and duration to penetrate the skin and activate the photosensitizer; (b) removing from the skin area substantially all of the liposome composition which is not introduced into the hair follicle ducts; and (c) applying light to the skin area at an appropriate wavelength, energy and duration to penetrate the skin and cause the photosensitizer to undergo a reaction to damage the hair follicles. The present invention also provides a composition useful for hair removal.Type: GrantFiled: February 27, 1996Date of Patent: November 7, 2000Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Maria M. Zuk, Wai-Shun Chan
-
Patent number: 6103706Abstract: The present invention provides a method for treating a viral infection in a subject in need of such treatment comprising administering to the subject a photosensitizer formulated in a liposome carrier, and exposing the subject to light at a wavelength 20-40 nm greater than the maximum absorption of the photosensitizer at a sufficient dose and duration to treat the viral infection in the subject. The present invention also provides a method for treating a viral infection in a subject in need of such treatment comprising administering to the subject (i) a photosensitizer formulated in a liposome carrier and (ii) at least one quencher, and exposing the subject to light at a sufficient wavelength, dose and duration to treat the viral infection in the subject.Type: GrantFiled: April 29, 1997Date of Patent: August 15, 2000Assignee: New York Blood Center, Inc.Inventor: Ehud Ben-Hur
-
Patent number: 6090599Abstract: Disclosed are two processes.Type: GrantFiled: September 1, 1998Date of Patent: July 18, 2000Assignee: New York Blood Center, Inc.Inventor: Ehud Ben-Hur
-
Patent number: 6087141Abstract: The present invention concerns a process for inactivating extracellular and intracellular virus in a biological composition without incurring substantial disruption or inactivation thereof, said process comprising subjecting said composition to a virucidally effective amount of UVA1 irradiation substantially in the absence of UVA2 irradition for a period of time sufficient to thereby inactivate said virus while retaining functionality of said composition. The biological composition is advantageously a product that contains red blood cells or platelets. The process is advantageously carried out in the presence of an irradiation sensitizer compound and/or a quencher. The present invention also concerns the product substantially identical to that produced bythe inventive process.Type: GrantFiled: August 4, 1998Date of Patent: July 11, 2000Assignee: New York Blood Center, Inc.Inventors: Henrietta Margolis-Nunno, Ehud Ben-Hur, Bernard Horowitz
-
Patent number: 6077659Abstract: An improved process is disclosed for photodynamically inactivating viruses in red blood cell containing compositions by adding vitamin E or a derivative thereof, such as Trolox, to the red blood cell and photosensitizer containing composition prior to irradiation. Addition of vitamin E or derivative thereof is protective of the red blood cells but not the viruses to be inactivated. Cells irradiated in this manner exhibit reduced leakage of potassium ion, and reduced loss of negative charges from the cell membrane compared to cells treated in the absence of vitamin E or derivative. Red blood cells sterilized by this method are better preserved during storage and their life-time in the circulation in vivo is enhanced.Type: GrantFiled: November 16, 1994Date of Patent: June 20, 2000Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Shanti Rywkin, Bernard Horowitz
-
Patent number: 6010890Abstract: The present invention provides methods for reducing the level of infectious virus contained in red blood cell compositions. The methods comprise the steps of contacting the composition with a photosensitizer formulated in a liposome carrier, and exposing the composition to light at a sufficient wavelength, dose and duration to reduce the level of infectious virus contained in the composition. In the methods of the present invention, a quencher, either alone or formulated in a liposome carrier, also may be added to the red blood cell composition before application of light. The present invention also provides compositions containing photosensitizers formulated in specific liposome carriers, as well as quenchers formulated in liposome carriers, for use in the methods of the present invention.Type: GrantFiled: April 29, 1997Date of Patent: January 4, 2000Assignee: New York Blood Center, Inc.Inventors: Ehud Ben-Hur, Maria M. Zuk
-
Patent number: 5985331Abstract: This invention relates to a method for inactivating parasites in blood cell-containing compositions by incubating a mixture of the blood cell-containing composition, a phthalocyanine dye and a quencher and optionally irradiating this mixture with red light. This invention further relates to a method of sterilizing blood cell-containing compositions which contain lipid enveloped viruses and blood borne parasites.Type: GrantFiled: June 5, 1998Date of Patent: November 16, 1999Assignee: New York Blood Center, Inc.Inventors: Paul Gottlieb, Ehud Ben-Hur, Sara Lustigman